Product Information

LEVORPHANOL 2 MG TABLET is a generic product labeled by Lannett Company Inc., priced at $16.3940 per EA under NDC 00527323637. Its NADAC has been published 108 times since Apr 17, 2024.

FDA first approved this application on Jul 1, 2020. Its Orange Book therapeutic-equivalence code is BX.

LEVORPHANOL 2 MG TABLET

Levorphanol Tartrate
$16.3940per EA
DEA Schedule CII

Strength

2 mg/1

NDC

00527323637

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Effective Date

11/18/2026

Active Ingredients

LEVORPHANOL TARTRATE

Approval Type

Generic (ANDA)

FDA Application

ANDA213479

FDA Approved

7/1/2020

TE Code

BX

On Market Since

5/20/2019

Pharmacological Classes

Full Opioid Agonists
Opioid Agonist

Price Statistics

The NADAC for LEVORPHANOL 2 MG TABLET has been published 108 times since Apr 17, 2024, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.

Current price$16.3940 per EA
All-time high$20.2966 (May 14, 2025)
All-time low$10.6456 (Feb 18, 2026)
52-week high$18.1292
52-week low$10.6456
Median price$16.0770
Average price$14.8715
Largest weekly change+70.3% (Oct 21, 2026)
Weeks tracked108
Tracking sinceApr 17, 2024

Price History

1W

-9.6%

1M

+54.0%

3M

+54.0%

6M

+54.0%

1Y

+12.4%

3Y

N/A

5Y

N/A

All

+2.0%

Generic Alternatives

The matcher finds 4 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 35% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of LEVORPHANOL 2 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for LEVORPHANOL 2 MG TABLET, manufactured by Lannett Company Inc., is $16.3940 per EA (NDC 00527323637), effective Nov 18, 2026.

How has the price of LEVORPHANOL 2 MG TABLET changed over time?

Over the history we have for it, the NADAC for LEVORPHANOL 2 MG TABLET has held within roughly two percent of its current level. It has been tracked across 108 weekly CMS publications since Apr 17, 2024.

What are the highest and lowest recorded NADAC prices for LEVORPHANOL 2 MG TABLET?

Since Apr 17, 2024, the NADAC for LEVORPHANOL 2 MG TABLET has ranged from a low of $10.6456 (Feb 18, 2026) to a high of $20.2966 (May 14, 2025), with a median of $16.0770 per EA.

Are there cheaper alternatives to LEVORPHANOL 2 MG TABLET?

Yes. 4 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, LEVORPHANOL 2 MG TABLET, is $10.6456 per EA — about 35% below LEVORPHANOL 2 MG TABLET.

Who manufactures LEVORPHANOL 2 MG TABLET?

LEVORPHANOL 2 MG TABLET (NDC 00527323637) is labeled by Lannett Company Inc., and CMS classifies it as a generic product.